Suppr超能文献

小儿尿路上皮膀胱癌。

Pediatric urothelial bladder neoplasm.

机构信息

Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.

Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.

出版信息

J Pediatr Urol. 2022 Dec;18(6):833.e1-833.e4. doi: 10.1016/j.jpurol.2022.06.026. Epub 2022 Jun 30.

Abstract

INTRODUCTION

Urothelial bladder neoplasm (UBN) is an uncommon lesion in children and adolescents, without established follow-up protocol defined for this patient group.

OBJECTIVES

To report our experience and long-term follow-up data on pediatric patients with urothelial carcinoma of the urinary bladder.

METHODS

In this retrospective two center study, we analyzed the perioperative and long-term follow-up data of nine pediatric patients, who presented with neoplasms of urothelial origin within the urinary bladder between 2000 and 2021.

RESULTS

Nine patients were identified with a mean age of 11.9 years (range 4-19 years) and median follow up of 48 months (range 12-160 month). 7 were male. Gross hematuria was the most common presenting symptom, occurring in 6 patients, followed by accidental finding on US, performed for other reasons. Cystoscopy was performed under general anesthesia, and transurethral resection of the bladder tumors was carried out in the same session. All patients had a solitary tumor with a mean size of 11 mm (range 6-15 mm). Pathology revealed 3 cases of papillary urothelial neoplasm of low malignant potential (PUNLMP), 5 cases of low grade (LG) noninvasive urothelial carcinoma (UC) and one case of high-grade (HG) UC invading lamina propria (pT1). All 8 patients with low grade tumor underwent follow up according to adult follow-up protocols without tumor recurrences to date. The single patient with HG pT1 UC, a 14-year-old female after renal transplantation, who was not eligible for intravesical bacillus Calmette-Guerin (BCG) installations due to immunosuppression, underwent 6 sessions of Radiofrequency-induced Thermo-chemotherapy with mitomycin, without complications. She had no recurrence to date, during a 4-year post treatment follow up.

CONCLUSION

Pediatric non muscle invasive bladder cancer (NMIBC), seems to have a good prognosis with infrequent recurrences, which might be in favor of a more spacious follow up plan with less invasive diagnostic modalities as opposed to adult NMIBC population. To the best of our knowledge this is the single description of Heated Intravesical Chemotherapy efficacy for HG UC in the pediatric population.

摘要

介绍

儿童和青少年的尿路上皮膀胱肿瘤(UBN)较为少见,目前尚未为该患者群体制定明确的随访方案。

目的

报告我们在儿童尿路上皮膀胱癌患者中的经验和长期随访数据。

方法

在这项回顾性的两中心研究中,我们分析了 2000 年至 2021 年间,9 名在膀胱出现尿路上皮起源肿瘤的儿科患者的围手术期和长期随访数据。

结果

9 名患者的平均年龄为 11.9 岁(范围 4-19 岁),中位随访时间为 48 个月(范围 12-160 个月)。7 名男性。最常见的首发症状是肉眼血尿,有 6 例患者出现,其次是因其他原因进行的超声偶然发现。膀胱镜检查在全身麻醉下进行,同期进行经尿道膀胱肿瘤切除术。所有患者均为单发肿瘤,平均大小为 11mm(范围 6-15mm)。病理显示 3 例为低级别(LG)非浸润性尿路上皮癌(UC)伴低级别(LG)尿路上皮乳头状肿瘤(PUNLMP),5 例为高级别(HG)UC 侵犯固有层(pT1)。所有 8 例低级别肿瘤患者均按照成人随访方案进行随访,目前无肿瘤复发。唯一 1 例 HG pT1 UC 患者为 14 岁女性,肾移植后因免疫抑制不适合行膀胱内卡介苗(BCG)灌注,接受了 6 次射频诱导热化学治疗联合丝裂霉素,无并发症。在 4 年的治疗后随访中,她没有复发。

结论

儿童非肌肉浸润性膀胱癌(NMIBC)似乎预后良好,复发率较低,这可能有利于采用更宽松的随访方案和侵袭性较小的诊断方法,而不是采用成人 NMIBC 人群的方案。据我们所知,这是唯一描述在儿科人群中应用加热膀胱内化疗治疗 HG UC 的疗效的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验